Literature DB >> 7880735

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.

P L Olive1.   

Abstract

The possibility of using tirapazamine (SR 4233) to identify hypoxic cells in multicell spheroids and murine tumours was examined by measuring tirapazamine-induced DNA damage to individual cells from multicell spheroids and SCCVII murine tumours. Fluorescence microscopy and image analysis were used to measure the extent of migration of DNA from individual cells embedded in agarose and exposed to an electric field. Using both the alkaline and neutral versions of the comet assay, at least 20 times more single-strand breaks were observed in cells from fully anoxic than fully oxic Chinese hamster V79 spheroids exposed to 30 microM tirapazamine, and about 10 times more single- than double-strand breaks were observed. Cells from spheroids containing about 50% radiobiologically hypoxic cells showed a pattern of tirapazamine breaks which translated to approximately 30% well-oxygenated in SCCVII tumors growing in C3H mice was also demonstrated. Cells close to tumour blood vessels showed less DNA damage by 20 mg kg-1 tirapazamine than cells distant from blood vessels. Rejoining of single-strand breaks was exponential, with a half-time of about 1 h under aerobic conditions, but rejoining half-time increased to 2 h for cells allowed to repair under anoxic conditions. While tirapazamine damage to DNA measured using the comet assay cannot provide a direct measure of hypoxic fraction, the degree of heterogeneity in DNA damage can be used to estimate the range and distribution of individual cell oxygen contents within spheroids and tumours.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7880735      PMCID: PMC2033654          DOI: 10.1038/bjc.1995.105

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay.

Authors:  P L Olive; J P Banáth; R E Durand
Journal:  Radiat Res       Date:  1990-04       Impact factor: 2.841

2.  Letter: Studies on the radiosensitizing effect of oxygen in Chinese hamster cells.

Authors:  J D Chapman; D L Dugle; A P Reuvers; B E Meeker; J Borsa
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1974-10

3.  Some biochemical consequences of the spatial distribution of ionizing radiation-produced free radicals.

Authors:  J F Ward
Journal:  Radiat Res       Date:  1981-05       Impact factor: 2.841

4.  Pre- and post-irradiation radiosensitization by SR 4233.

Authors:  E M Zeman; J M Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-04       Impact factor: 7.038

5.  Intermittent blood flow in a murine tumor: radiobiological effects.

Authors:  D J Chaplin; P L Olive; R E Durand
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

6.  SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.

Authors:  E M Zeman; J M Brown; M J Lemmon; V K Hirst; W W Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-07       Impact factor: 7.038

7.  Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusion.

Authors:  P L Olive
Journal:  Radiother Oncol       Date:  1994-07       Impact factor: 6.280

8.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells.

Authors:  O Ostling; K J Johanson
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

9.  Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233).

Authors:  K Laderoute; P Wardman; A M Rauth
Journal:  Biochem Pharmacol       Date:  1988-04-15       Impact factor: 5.858

10.  Bioreductive drugs and the selective induction of tumour hypoxia.

Authors:  J C Bremner; I J Stratford; J Bowler; G E Adams
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

View more
  6 in total

1.  Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.

Authors:  Hebist Berhane; Michael W Epperly; Julie Goff; Ronny Kalash; Shaonan Cao; Darcy Franicola; Xichen Zhang; Donna Shields; Frank Houghton; Hong Wang; Peter Wipf; Kalindi Parmar; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

2.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting.

Authors:  Yvette M Delahoussaye; Michael P Hay; Frederik B Pruijn; William A Denny; J Martin Brown
Journal:  Biochem Pharmacol       Date:  2003-06-01       Impact factor: 5.858

4.  Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.

Authors:  P L Olive; R E Durand; J A Raleigh; C Luo; C Aquino-Parsons
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

5.  Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.

Authors:  B G Siim; P L van Zijl; J M Brown
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

6.  Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.

Authors:  R M Phillips; P M Loadman; B P Cronin
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.